New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
04:55 EDTSI, SI, SI, THOR, THOR, THOR, STJ, STJ, STJ, ATRC, ATRC, ATRC, CADX, CADX, CADX, COV, COV, COV, CRY, CRY, CRY, EW, EW, EW, HTWR, HTWR, HTWR, ISRG, ISRG, ISRG, MDT, MDT, MDT, MYGN, MYGN, MYGN, RTIX, RTIX, RTIX, WTKWY, WTKWY, WTKWYAmerican Association for Thoracic Surgery to hold annual meeting
94th Annual Meeting of AATS is being held in Toronto on April 26-30.
News For SI;RTIX;MYGN;MDT;ISRG;HTWR;EW;CRY;COV;CADX;ATRC;STJ;THOR;WTKWY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
January 14, 2015
16:07 EDTATRC AtriCure names Douglas Seith as COO and Andy Wade as CFO
AtriCure, Inc. announced that Douglas Seith will assume the role of COO. Douglas Seith will now be responsible for all global commercial organizations as well as education and clinical science programs. The company also announced that Andy Wade has been promoted to senior VP and CFO.
13:14 EDTTHORThoratec says timing of 2015 market growth reacceleration 'uncertain'
Subscribe for More Information
10:00 EDTWTKWYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:03 EDTSTJSt. Jude Medical sees Q4 adjusted EPS within $1.02-$1.04 guidance range
Subscribe for More Information
09:02 EDTSTJSt. Jude Medical sees Q4 net sales approximately $1.439B, consensus $1.44B
Subscribe for More Information
09:01 EDTSTJSt. Jude Medical authorizes $500M share repurchase program
The company announced that its board of directors has authorized the repurchase of up to $500M of St. Jude Medical common stock. The repurchases will occur at such times and at such prices as the management of the company determines and may be effected through transactions in the open market, in privately negotiated transactions or otherwise. Any shares acquired in the $500M repurchase program will be available for general corporate purposes, including offsetting dilution associated with stock option and other equity-based employee benefit plans. The company had approximately 287 million shares of common stock outstanding as of Jan. 13, 2015.
January 13, 2015
17:20 EDTWTKWYWolters Kluwer upgraded to Conviction Buy from Sell at Goldman
Goldman upgraded Wolters Kluwer multiple notches to Conviction Buy from Sell citing an improving outlook.
11:08 EDTHTWRHeartWare CEO comments on clinical progress
Subscribe for More Information
11:07 EDTHTWRHeartWare sees FY14 revenue approximately $278M, consensus $276.55M
"Our full-year revenue growth of 34% for 2014 above 2013 reflects the strong market penetration we have experienced to date for the HeartWare Ventricular Assist System in both the U.S. and international markets," said Doug Godshall, President and CEO. "Fourth quarter 2014 unit sales increased by approximately 9 percent sequentially compared to the third quarter of 2014, a key driver of our strong revenue performance."
11:06 EDTHTWRHeartWare sees Q4 revenue approximately $73M, consensus $71.24M
Subscribe for More Information
08:40 EDTISRGIntuitive Surgical reports preliminary Q4 revenue $605M, consensus $587.48M
Intuitive Surgical announced certain unaudited preliminary Q4 financial results. The company expects GAAP revenue for Q4 of approximately $605M, up approximately 5% from $576M for the 4Q13. The company expects non-GAAP revenue for Q4 of approximately $601M, which excludes approximately $4M of revenue associated with da Vinci Xi trade-out offers. The unaudited preliminary results are prior to the completion of our annual independent audit and therefore are subject to adjustment. Preliminary Q4 instruments and accessories revenue on a GAAP basis is expected to increase approximately 5% to approximately $281M from $268M during 4Q13. Preliminary fourth quarter 2014 da Vinci Surgical Systems revenue on a GAAP basis is expected to increase approximately 5% to approximately $214M from $205M during 4Q13. The company placed 137 da Vinci Surgical Systems during Q4, compared with 138 systems during 4Q13. The Preliminary Q4 GAAP service revenue is expected to increase approximately 6% to approximately $110M from $103M during 4Q13.
08:36 EDTHTWRHeartWare announces first patient implant in HVAD LATERAL Study
HeartWare International announced the first patient implant in the HVAD LATERAL Study, a U.S. Investigational Device Exemption, or IDE, clinical trial in which the HeartWare Ventricular Assist System, featuring the HVAD Pump, is implanted through a less-invasive thoracotomy procedure in patients with end-stage heart failure who are awaiting a heart transplant.
07:42 EDTHTWRJPMorgan to hold a conference
33rd Annual Healthcare Conference is being held in San Francisco on January 12-15 with webcasted company presentations to begin on January 13 at 10:30 am; not all company presentations may be webcasted. Webcast Link
January 12, 2015
13:02 EDTCOV, MDTMedtronic sees Coviden deal closing in last week of January, early February
Subscribe for More Information
11:08 EDTCOVEMC says Elliott agrees to certain limited standstill provisions through Sept.
Subscribe for More Information
08:38 EDTATRCAtriCure sees FY15 revenue $122.5M-$124.5M, consensus $122.95M
At current foreign exchange rates, this FY15 range reflects an estimated $1.6M adverse currency impact due to the weakening Euro against the U.S. Dollar. AtriCure sees FY15 adjusted EBITDA to be a loss in the range of ($7M)-($9M), as the company continues to make strategic investments to drive long-term growth.
08:36 EDTATRCAtriCure sees FY14 revenue $107.5M, consensus $105.72M
08:36 EDTATRCAtriCure sees Q4 revenue $29.5M, consensus $27.69M
Subscribe for More Information
08:08 EDTISRGIntuitive Surgical procedures likely to exceed expectations, says SunTrust
Subscribe for More Information
07:17 EDTMYGN, STJJPMorgan to hold a conference
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use